Abstract:Here, we present a gene regulation strategy enabling programmable control over eukaryotic translational initiation. By excising the natural poly-adenylation (poly-A) signal of target genes and replacing it with a synthetic control region harboring RNA-binding protein (RBP)-specific aptamers, cap-dependent translation is rendered exclusively dependent on synthetic translation initiation factors (STIFs) containing different RBPs engineered to conditionally associate with different eIF4F-binding proteins (eIFBPs). This modular design framework facilitates the engineering of various gene switches and intracellular sensors responding to many user-defined trigger signals of interest, demonstrating tightly controlled, rapid and reversible regulation of transgene expression in mammalian cells as well as compatibility with various clinically applicable delivery routes of in vivo gene therapy. Therapeutic efficacy was demonstrated in two animal models. To exemplify disease treatments that require on-demand drug secretion, we show that a custom-designed gene switch triggered by the FDA-approved drug grazoprevir can effectively control insulin expression and restore glucose homeostasis in diabetic mice. For diseases that require instantaneous sense-and-response treatment programs, we create highly specific sensors for various subcellularly (mis)localized protein markers (such as cancer-related fusion proteins) and show that translation-based protein sensors can be used either alone or in combination with other cell-state classification strategies to create therapeutic biocomputers driving self-sufficient elimination of tumor cells in mice. This design strategy demonstrates unprecedented flexibility for translational regulation and could form the basis for a novel class of programmable gene therapies in vivo.

Design and Construction of a Versatile Synthetic Network for Bistable Gene Expression in Mammalian Systems

Small-molecule-based regulation of RNA-delivered circuits in mammalian cells

A synthetic transcription platform for programmable gene expression in mammalian cells

A More Efficient RNAi Inducible System for Tight Regulation of Gene Expression in Mammalian Cells and Xenograft Animals.

Orthogonal Protein-Responsive mRNA Switches for Mammalian Synthetic Biology

A tunable, rapid, and precise drug control of protein expression by combining transcriptional and post-translational regulation systems

A Platform For Rapid Prototyping Of Synthetic Gene Networks In Mammalian Cells

Engineered poly(A)-surrogates for translational regulation and therapeutic biocomputation in mammalian cells

USE OF TALE TRANSCRIPTIONAL REPRESSOR FOR MODULATOR CONSTRUCTION OF SYNTHETIC GENE LINE IN MAMMALIAN CELLS

A synthetic metabolite-based mammalian inter-cell signaling system

Self-feedback loop-containing synthetic mRNA switches for controlled microRNA sensing

Synthetic translational coupling element for multiplexed signal processing and cellular control

Enhanced Target Gene Knockdown by a Bifunctional Shrna: a Novel Approach of RNA Interference

Dual Input-Controlled Synthetic mRNA Circuit for Bidirectional Protein Expression Regulation

Bicistronic gene transfer tools for delivery of miRNAs and protein coding sequences

Multifunctional Systems in Synthetic Biology: Single-Stranded DNA Signaling for Precise Control of Gene Activation

Use of tale transcriptional repressor for modular construction of synthetic gene line in mammalian cell

Development of a Multipurpose GATEWAY-Based Lentiviral Tetracycline-Regulated Conditional RNAi System (GLTR)

Modular Construction of Mammalian Gene Circuits Using TALE Transcriptional Repressors.

Rational design of microRNA-responsive switch for programmable translational control in mammalian cells

In-Vivo Real-Time Control of Protein Expression from Endogenous and Synthetic Gene Networks